Deep Learning-aided 1H-MR Spectroscopy for Differentiating between Patients with and without Hepatocellular Carcinoma
Magnetic Resonance in Medical Sciences · 2025
DOI: 10.2463/mrms.mp.2025-0064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medical Sciences, 2025. Verfasst von Jae Seok Bae und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Deep Learning, Liver Neoplasms, Carcinoma, Hepatocellular, Proton Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Seoul National University Hospital, College of Medicine, Seoul National University, National Research Foundation of Korea.
Abstract (Originalsprache)
PURPOSE: Among patients with hepatitis B virus-associated liver cirrhosis (HBV-LC), there may be differences in the hepatic parenchyma between those with and without hepatocellular carcinoma (HCC). Proton MR spectroscopy (1H-MRS) is a well-established tool for noninvasive metabolomics, but has been challenging in the liver allowing only a few metabolites to be detected other than lipids. This study aims to explore the potential of 1H-MRS of the liver in conjunction with deep learning to differentiate between HBV-LC patients with and without HCC. METHODS: Between August 2018 and March 2021, 1H-MRS data were collected from 37 HBV-LC patients who underwent MRI for HCC surveillance, without HCC (HBV-LC group, n = 20) and with HCC (HBV-LC-HCC group, n = 17). Based on a priori knowledge from the first 10 patients from each group, big spectral datasets were simulated to develop 2 kinds of convolutional neural networks (CNNs): CNNs quantifying 15 metabolites and 5 lipid resonances (qCNNs) and CNNs classifying patients into HBV-LC and HBV-LC-HCC (cCNNs). The performance of the cCNNs was assessed using the remaining patients in the 2 groups (10 HBV-LC and 7 HBV-LC-HCC patients). RESULTS: Using a simulated dataset, the quantitative errors with the qCNNs were significantly lower than those with a conventional nonlinear-least-squares-fitting method for all metabolites and lipids (P ≤0.004). The cCNNs exhibited sensitivity, specificity, and accuracy of 100% (7/7), 90% (9/10), and 94% (16/17), respectively, for identifying the HBV-LC-HCC group. CONCLUSION: Deep-learning-aided 1H-MRS with data augmentation by spectral simulation may have potential in differentiating between HBV-LC patients with and without HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Seoul National University Hospital, Seoul, Korea.
- Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
- METLiT Inc., Seoul, Korea.
- Department of Medical Sciences, Seoul National University College of Medicine, Seoul, Korea.
- Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea.
- Department of Radiology, Seoul Metropolitan Government-Seoul National University Boramae medical center, Seoul, Korea.
Förderung
- Seoul National University Hospital
- College of Medicine, Seoul National University
- National Research Foundation of Korea
Zitieren
APA
Bae, J. S., Lee, H. H., Kim, H., Song, I. C., Lee, J. Y., & Han, J. K. (2025). Deep Learning-aided 1H-MR Spectroscopy for Differentiating between Patients with and without Hepatocellular Carcinoma. Magnetic Resonance in Medical Sciences. https://doi.org/10.2463/mrms.mp.2025-0064
Vancouver
Bae JS, Lee HH, Kim H, Song IC, Lee JY, Han JK. Deep Learning-aided 1H-MR Spectroscopy for Differentiating between Patients with and without Hepatocellular Carcinoma. Magnetic Resonance in Medical Sciences. 2025. doi:10.2463/mrms.mp.2025-0064
BibTeX
@article{Bae2025,
author = {Bae, Jae Seok and Lee, Hyeong Hun and Kim, Hyeonjin and Song, In Chan and Lee, Jae Young and Han, Joon Koo},
title = {Deep Learning-aided 1H-MR Spectroscopy for Differentiating between Patients with and without Hepatocellular Carcinoma},
journal = {Magnetic Resonance in Medical Sciences},
year = {2025},
doi = {10.2463/mrms.mp.2025-0064}
}
EUVIMED